WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a note issued to investors on Saturday.
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of WORK Medical Technology Group in a report on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, WORK Medical Technology Group has a consensus rating of “Sell”.
Get Our Latest Analysis on WORK Medical Technology Group
WORK Medical Technology Group Stock Performance
WORK Medical Technology Group (NASDAQ:WOK – Get Free Report) last posted its earnings results on Friday, August 14th. The company reported ($98.88) earnings per share for the quarter. The business had revenue of $2.71 million for the quarter.
Insiders Place Their Bets
In other WORK Medical Technology Group news, major shareholder Financial Lp Hrt sold 136,665 shares of the business’s stock in a transaction that occurred on Thursday, June 18th. The shares were sold at an average price of $3.87, for a total transaction of $528,893.55. Following the sale, the insider directly owned 123,944 shares of the company’s stock, valued at $479,663.28. The trade was a 52.44% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Over the last 90 days, insiders have purchased 960,133 shares of company stock worth $957,353 and have sold 180,440 shares worth $984,223.
WORK Medical Technology Group Company Profile
WORK Medical Technology Group Ltd. engages in developing health instruments. It manufactures and sells medical devices, including endotracheal tubes, laryngeal mask airways, heat and moisture exchanging filters, disposable breathing circuits, nebulizer kits, and yankauer suction sets. The company was founded on March 1, 2022 and is headquartered in Hangzhou, China.
Read More
- Five stocks we like better than WORK Medical Technology Group
- VIG, VYM, and VYMI: Which Vanguard Dividend ETF Is Right for You?
- 3 Closed-End Funds to Maximize Dividend Payments
- Rocket Lab’s Sell-Off Is Fading—Is It Finally Safe to Buy?
- $27 Billion in Buybacks: 3 Stocks Betting Their Strong Runs Aren’t Over
Receive News & Ratings for WORK Medical Technology Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WORK Medical Technology Group and related companies with MarketBeat.com's FREE daily email newsletter.
